A new malaria vaccine could be the first to tackle different forms of the disease and help those most vulnerable to infection, a study suggests.
Quoted from Multiple malaria vaccine offers protection to people most at risk on ScienceDaily: Top News
Malaria vaccine development has been stymied thus far by the plex, multi-host, multi-stage life cycle of the major malarial parasite Plasmodium falciparum (see following figure). falciparum malaria. These MAP vaccines were based on immunodominant B-cell and T-cell epitopes from the major malaria vaccine candidates, circumsporozoite protein (CSP), liver stage antigen 1 (LSA-1), merozoite surface protein 1 (MSP-1) and MSP-3, serine The PfSPZ is a candide developed by Sanaria using radiion-tenued sporozoites elicit an immune response. Clinical trials have been promising, with trials taking place in Africa, Europe, and the US protecting Tags: malaria, vaccine, wikipedia, Experimental PfSPZ malaria vaccine provides “An effective will need protect living in endemic areas against strains of the mosqui-borne disease.” An investigional has protected a small number of healthy U.S. adults from infection Develop and license s with protective efficacy of least 75% against clinical for areas with ongoing transmission. Develop s th reduce transmission and human infection, enabling eliminion in